Intralytix, Inc. specializes in the development and marketing of bacteriophage-based products aimed at controlling bacterial pathogens in various settings, including environmental, food processing, and medical applications. Bacteriophages, often referred to as "bacteria-eaters," are natural viruses that specifically target and kill harmful bacteria without disrupting the beneficial microbiome. The company's product line includes solutions like Shield™, EcoShield™, and SalmoFresh™, which are designed to combat specific pathogens such as Listeria monocytogenes, Shiga toxin-producing E. coli, and Salmonella. These products have received multiple regulatory approvals, including from the FDA and Health Canada, and are recognized for their safety and efficacy in food applications.

Intralytix's approach to food safety leverages the unique properties of bacteriophages, which are abundant in nature and have been shown to effectively reduce or eliminate targeted bacterial pathogens in food products. The company emphasizes the natural and non-chemical nature of its phage preparations, which are designed to be easy to apply and cost-effective for food processing facilities. With a commitment to innovation, Intralytix has established itself as a leader in the field of phage biocontrol, holding the largest portfolio of FDA- and USDA-approved bacteriophage products for food safety. Their solutions not only enhance food safety but also help food producers mitigate the risk of contamination and improve compliance with regulatory standards.

United States

Intralytix, Inc. is a biotechnology company focused on the discovery, production and marketing of bacteriophage-based products to control bacterial pathogens in environmental, food processing, and medical settings. The company makes phage that target E. coli, Salmonella, and Listeria in pet and human food.Intralytix has developed and is continuing to develop phage preparations for preventing and treating bacterial diseases of pets and other animals, including agriculturally-important animals. Other products include phage mixtures as probiotics.Intralytix’s is also developing phage preparations for treating infected wounds.

Intralytix

Company Details